In This Webinar...

There is an increasing need to leverage real-world data to accelerate clinical development and reduce unnecessary spend. The true value of real-world data lies in the ability to link datasets for multiple use cases. Linkage between real-world datasets is possible without tokenization due to the patient-identifiable data points captured as part of health records and claims data. And though there are regulatory requirements that govern the handling of patient-identified data and the use cases thereafter, the likelihood of success in creating linked datasets is high. However, due to the need to preserve subject-level anonymity within the confines of regulated clinical research, tokenization of the clinical development data becomes key to enable the linkage of clinical development data with real-world data.

Learning Objectives:

At the conclusion of this webinar, participants should be able to understand:

• Understand the current real-world data landscape for clinical development including Merative’s experience supporting customer use cases
• Understand the benefits and approach of linking and leveraging clinical development data with real-world data
• How tokenization supports the linkage of clinical development data to enable expanded real-world data use cases
• How technology and trial design decisions impact the ability to tokenize and link clinical development data for real-world data related use cases

Featured Topics:

• The importance of establishing a linkable data infrastructure to help life science companies link clinical trial data and real-world data to their clinical trial any time
• How the use of real-world data can enable pharmaceutical, medical device and research organizations to optimize and accelerate trial phases
• Use cases of clinical development and real-world data

Presenters: